In-Utero Sugar Restriction Cuts Offspring's Risk for Diabetes, Hypertension
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 7, 2024 -- Sugar restriction during the first 1,000 days after conception lowers a child's risk for later developing type 2 diabetes and hypertension, according to a study published online Oct. 31 in Science.
Tadeja Gracner, Ph.D., from the University of Southern California in Los Angeles, and colleagues examined the impact of sugar exposure within 1,000 days since conception on diabetes and hypertension. The analysis used a quasi-experimental design based on data from adults conceived just before and after the end of the United Kingdom sugar rationing in September 1953, which restricted sugar intake to levels within current dietary guidelines. Consumption nearly doubled immediately after rationing ended.
The researchers found that early-life rationing reduced diabetes and hypertension risk by about 35 and 20 percent, respectively. Similarly, rationing delayed disease onset by four and two years, respectively. With in-utero exposure restriction, protection was seen and increased with postnatal sugar restriction, especially after six months when solid foods likely began. One-third of the risk reduction was accounted for by in-utero sugar rationing.
"Parents need information about what works, and this study provides some of the first causal evidence that reducing added sugar early in life is a powerful step towards improving children's health over their lifetimes," coauthor Claire Boone, from McGill University in Montreal and the University of Chicago, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-08 06:00
Read more
- Climate Change to Blame for Almost 1 in 5 New Dengue Infections
- FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
- Antiviral Treatment Underutilized for Children, Teens With Flu
- Bystanders More Readily Perform CPR If 911 Operator Instructs
- Diabetes Meds Metformin, GLP-1s Can Also Curb Asthma
- Newborn Genome Analysis Spots More Health Issues Than Standard Screening
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions